Development of safer molecules through chirality

PA Patil, MA Kothekar - 2006 - tspace.library.utoronto.ca
Many of the drugs currently used in medical practice are mixtures of enantiomers
(racemates). Many a times, the two enantiomers differ in their pharmacokinetic and …

The potential anti-inflammatory benefits of improving physical fitness in hypertension

KM Edwards, MG Ziegler, PJ Mills - Journal of hypertension, 2007 - journals.lww.com
Hypertension is associated with an increased risk of stroke and atherosclerosis. In addition
to elevated blood pressure, hypertension is characterized by neuroendocrine and immune …

The Significance of Chirality in Pharmacological and Toxicological Properties of Drugs

AA Spasov, IN Iezhitsa, PM Vassiliev… - Pharmacology of Drug …, 2022 - Springer
The effect of differences in the stereochemistry of drugs on their pharmacokinetic and
pharmacodynamic properties has been recognized for long. In recent years, technological …

Can natriuretic peptide levels predict the cardiovascular complications of COX-2 inhibitors and nonsteroidal anti-inflammatory drugs?

RP Blankfield - The Journal of the American Board of Family …, 2006 - Am Board Family Med
There is evidence that fluid retention, whether due to a disease process or due to a
medication, is associated with a number of cardiovascular diseases, including heart failure …

[PDF][PDF] Prevalence of Calcium Channel Blocker Induced Ankle Edema and its Treatment in a Cohort of Newly Diagnosed Hypertensive Patients

PO Onah, CC Idoko, S Abdulateef - 2022 - ijpsm.com
Background: Calcium channel blockers are widely prescribed either as monotherapies or in
combination therapies in the management of hypertension and other cardiovascular …

[BOOK][B] Collecting lymphatic vessel permeability to albumin and its modification by natriuretic peptides

J Scallan - 2010 - search.proquest.com
Macromolecules and water leave the blood microcirculation and bathe the tissues of the
body, and cannot be constitutively reabsorbed by the blood vessels, necessitating an …

" Новые" антагонисты кальция в лечении сердечно-сосудистых заболеваний

ЛМ Житникова - РМЖ, 2010 - elibrary.ru
Выделяют шесть типов кальциевых каналов, но основное клиническое значе ние
имеют каналы L–и Т–типа. Все при меняемые в настоящее время АК (в том числе и …

Сравнительная оценка влияния терапии антагонистами кальция фелодипином и амлодипином на баланс водных секторов организма женщин с …

МГ Глезер, МВ Новикова, НЛ Проурзина… - Проблемы женского …, 2009 - elibrary.ru
Антагонисты кальция являются препаратами выбора при артериальной гипертензии.
Наиболее широкое применение получили дигидропиридиновые антагонисты кальция …

[PDF][PDF] Хиральность кардиологических препаратов: миф или реальность

АВ Максименко - Кардиологический вестник, 2010 - cardioweb.ru
Аннотация Оптически активные стереоизомеры оказались действенным ресурсом для
разработки новых лекарственных средств. При этом S-и R-энантиомеры рацематов …

Technology Development for the Synthesis of S-Amlodipine Nicotinate Drug Substance

GA Kim, ZM Kozlova, SO Pchelintsev… - Pharmaceutical …, 2017 - Springer
Technology for the synthesis of S-amlodipine nicotinate drug substance was developed
based on an acceptable method of effective separation of the amlodipine optical isomers. A …